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Background: Polymyxin B resistance protein D (PmrD) plays a key role in the polymyxin B-resistance pathway, as it
is the signaling protein that can act as a specific connecter between PmrA/PmrB and PhoP/PhoQ. We conducted
structural analysis to characterize Escherichia coli (E. coli) PmrD, which exhibits different features compared with
PmrD in other bacteria.
Results: The X-ray crystal structure of E. coli PmrD was determined at a 2.00 Å resolution, revealing novel information
such as the unambiguous secondary structures of the protein and the presence of a disulfide bond. Furthermore,
various assays such as native gel electrophoresis, surface plasmon resonance (SPR), size-exclusion chromatography,
dynamic light scattering (DLS), and small-angle X-ray scattering (SAXS) measurements, were performed to
elucidate the structural and functional role of the internal disulfide bond in E. coli PmrD.
Conclusions: The structural characteristics of E. coli PmrD were clearly identified via diverse techniques. The
findings help explain the different protective mechanism of E. coli compared to other Gram-negative bacteria.
Keywords: PmrD, E. coli, SAXS, Crystal structure, Solution structure, Mutational studyBackground
Various antibiotics have been widely used to inhibit
bacterial growth or to kill bacteria. Polymyxin B, isolated
from the bacterium Paenibacillus polymyxa, is one of the
most potent antibiotics. It binds to lipopolysaccharide
(LPS), the major component of the outer membrane
of Gram-negative bacteria [1]. Because Gram-negative
bacteria display the negatively charged LPS on the
surface of the outer membrane, the cationic polymyxin B
can interact with phospholipids to make the membrane
permeable, resulting in the acceleration of water uptake,
membrane disruption, and endotoxin release. It acts as a
detergent against most Gram-negative bacteria, with the
exception of the Proteus group [2-4].
Gram-negative bacteria have developed different pro-
tective mechanisms to counteract the effects of poly-
myxin B. For instance, Salmonella enterica (S. enterica)
possesses a pair of two-component systems (TCSs) that* Correspondence: ciban@postech.ac.kr
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unless otherwise stated.are composed of PmrA/PmrB and PhoP/PhoQ. The
TCSs are known to modify the acyl chain group or the
phosphate group of LPSs, depending on environmental
conditions. There are two types of pathways that activate
the PmrA/PmrB system of polymyxin B resistance. The
first pathway transpires during the growth of bacteria in
the presence of high Fe3+ ion or mild acid pH and does
not require PhoP/PhoQ [5], only the histidine kinase
PmrB. The phosphorylation of PmrA by PmrB leads to
the transcription of PmrA-activated genes, resulting in the
modification of LPS layers. The second pathway includes
the PhoQ/PhoP system and PmrD in conditions of low
extracytoplasmic Mg2+ ions. PhoP is phosphorylated by
the sensor PhoQ protein; phosphorylated PhoP then pro-
motes the transcription of PmrD, a signaling protein that
can act as a specific connecter between PmrA/PmrB and
PhoP/PhoQ [6,7]. PmrD binds to the N-terminal domain
of PmrA to prevent the dephosphorylation of PmrA,
followed by the activation of the LPS modification process.
However, the PmrD protein of E. coli does not play a role
as a post-translational activator; thereby, the LPS modifi-
cation only occurs via the first pathway in E. coli. It isThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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teristics compared with the PmrD protein in other bac-
teria such as S. enterica and Klebsiella pneumoniae (KP).
Because the PmrD protein is affiliated to a new class of
proteins that utilize different mechanisms of action for
signal integration of bacterial cellular processes than those
found in other signaling proteins, the identification of
its structure and function is vital for a comprehensive
understanding of TCSs systems in bacteria [8]. There-
fore, the study of E. coli PmrD has been considered a
decisive factor for determining discrepancies among
several species [9-12].
In this study, we focus on exploring the structural
features of E. coli PmrD. The findings reveal the crystal
structure of E. coli PmrD in high resolution, and the
structural traits are described in detail. Diverse assays
were performed to determine the role of the internal
disulfide bond. In addition, the solution structures of
wild-type and mutant PmrD were determined using
SAXS to obtain structural information in the solution
environment.
Methods
Preparation of the proteins
The E. coli pmrD gene [UniProt: P37590] was isolated
from K-12 genomic DNA and amplified by polymerase
chain reaction (PCR) with specific primers. The amplified
genes were inserted into the bacterial expression vector
pET-15b (Novagen, Germany) containing the TEV pro-
tease cleavage site [12]. In addition, the C9A mutant
was generated by a point mutation to eliminate the
internal disulfide bond of PmrD. The His-tagged wild-
type and mutant PmrD were expressed in the E. coli
strain BL21(DE3) with Luria-Bertani broth containing
100 μg/L ampicillin, and were grown at 37°C to an
OD600 of ~0.6. The expression of soluble PmrD was
induced by the addition of 0.1 mM 1-thio-β-D-galacto-
side (IPTG), and the mixture was incubated in a shaker
for 6 h. The cell lysate was treated with lysozyme in
20 mM phosphate buffer (pH 7.4) containing 500 mM
NaCl and 2 mM β-mercaptoethanol. After sonication,
the lysate was centrifuged at 13,000 rpm at 4°C for the
removal of cell debris, and the resulting supernatant
was loaded onto a Ni-chelating Sepharose fast-flow
column charged with Ni ions (GE Healthcare Life
Science, Sweden). The contaminants were washed with
a washing buffer containing 20 mM phosphate (pH 7.5),
500 mM NaCl, 45 mM imidazole, and 2 mM β-
mercaptoethanol. Wild-type and mutant PmrD were
then eluted with washing buffer supplemented with
300 mM imidazole. The wild-type and mutant His-tagged
PmrD were digested by adding TEV protease at 20°C for
8 h. To remove the uncleaved His-tagged proteins, the
cleaved His-tagged fragments were reloaded for Ni-NTAaffinity chromatography, and the target proteins were
collected in the flow-through. For further purification,
the eluted fractions were concentrated using Ultracel
concentrators (Amicon) with a YM-10 membrane and
loaded onto a HL Superdex 75 column (GE Healthcare
Life Science, Sweden) equilibrated with 20 mM Tris
(pH 7.0), 150 mM NaCl, 0.5 mM DTT, and 0.5 mM
EDTA. Highly purified wild-type and mutant PmrD were
concentrated to approximately 7–15 mg/mL by centrifu-
gation and analyzed by 18% SDS-PAGE. In addition,
uncleaved His-tagged wild-type and mutant forms were
prepared for SPR measurement. The SeMet-substituted
PmrD expressed in E. coli B834 (DE3) was purified via the
same methods for native PmrD [12].
For the binding assay with PmrA, the E. coli pmrA
gene [UniProt: P30843] was isolated from K-12 genomic
DNA and amplified by PCR with specific primers, and
was then inserted into the bacterial expression vector
pET-28a (Novagen, Germany) containing the TEV protease
cleavage site. The recombinant PmrA was overexpressed in
the E. coli strain BL21(DE3) induced by 0.1 mM IPTG at
37°C, and purified as described above. The purity of PmrA
was proven via gel electrophoresis.Protein crystallization and data acquisition
Crystals of PmrD were produced via the hanging-drop
vapor-diffusion method at 20°C using 24-well Linbro
plates (Hampton Research). The initial crystals were
obtained after a period of one week at 20°C in 2.0 M
ammonium sulfate and 50 mM sodium acetate (pH 4.6).
Triclinic crystals were grown for one week to the
maximum dimensions of 0.35 × 0.35 × 0.2 mm3. SeMet-
substituted crystals were obtained in the same conditions.
The crystals were transferred to a cryo-protectant solution
and were flash-frozen in a nitrogen stream at 100 K. X-ray
crystallographic diffraction data were collected with an
ADSC Quantum 210 charge-coupled device (CCD) cam-
era as the detector from the Beamline 4A of the Pohang
Accelerator Laboratory (PAL) in Korea. The data for na-
tive PmrD and SeMet-substituted PmrD were collected,
integrated, and scaled using HKL2000 software [13]. The
data collection and processing statistics are summarized
in Additional file 1: Table S1.Structural determination and refinement
Using the NMR structure of E. coli PmrD [PDB: 2JSO]
as the starting model [14], phasing was performed via
molecular replacement using MOLREP [15] in the CCP4
suite. All model building was achieved with COOT [16]
and refined with REFMAC [17] and PHENIX software
[18]. Water picking was accomplished with PHENIX using
default parameters. The refined models were validated
with PROCHECK [19]. All figures for the structural model
Jo et al. BMC Structural Biology 2014, 14:24 Page 3 of 11
http://www.biomedcentral.com/1472-6807/14/24were made in PyMol [20]. The structure-refinement statis-
tics are also summarized in Additional file 1: Table S1.Accession numbers
The coordinate and structure factors for E. coli PmrD
have been deposited in the RCSB Protein Data Bank
(PDB), accession code 4HN7.Biochemical assays for the verification of the role of
disulfide bridge in PmrD
To investigate the role of the internal disulfide bridge in
PmrD, the binding affinities of wild-type and mutant
PmrD with PmrA were estimated via native gel electro-
phoresis. Sample solutions with various ratios of PmrD
to PmrA were prepared in 20 μL of reaction buffer
(20 mM Tris–HCl, pH 7.8, 5 mM MgCl2, and 100 mM
KCl) and incubated at 4°C for 1 h. Samples were loaded
onto a 4% native polyacrylamide gel that was pre-run at
12 V/cm for 20 min, and they were analyzed at room
temperature at 12 V/cm for 80 min in 1X TBE buffer.
In addition, the functional change of PmrD caused by
the disruption of the intra-disulfide bond was verified
thoroughly using a Biacore T100 biosensor system (GE
Healthcare, Sweden). A nickel solution was treated on
the NTA sensor chip (GE Healthcare, Sweden), and
then the His-tagged wild-type and mutant PmrD were
separately immobilized on the chip in the running buf-
fer (10 mM HEPES, 150 mM NaCl, 50 μM EDTA,
0.005% Tween 20, and pH 7.4). PmrA proteins with
various concentrations ranging from 0.1 to 5 μM were
applied to the PmrD-modified channel under continuous
flow of 20 μL/min at 25°C. All SPR signals were assessed
by a Biacore T100 response unit. The resulting data were
analyzed using BIAevaluation software (v3.0), and the
sensorgrams were reconstructed and examined using
Origin 8.0.
The average sizes of wild-type and mutant PmrD were
determined using size-exclusion chromatography. Based
on a high-performance liquid chromatography AKTA
system (GE Healthcare Life Science, Sweden), wild-type
and mutant PmrD were loaded onto the HL Superdex
75 column (GE Healthcare Life Science, Sweden). The
separation was carried out at 4°C at a flow rate of
1 mL/min with 25 mM HEPES (pH 7.0), 150 mM NaCl,
and 5% glycerol as the mobile phase, and was moni-
tored at an absorbance of 280 nm. Additionally, DLS is
also beneficial to evaluate the size of target molecules.
Each sample was prepared in solution containing 25 mM
HEPES (pH 7.0), 150 mM NaCl, and 5% glycerol, followed
by measurement in triplicate utilizing a Zetasizer Nano Z
(Malvern Instruments, Malvern, UK). The average size
distributions of the two types of PmrD are represented in
Additional file 2: Figure S1.Determining solution-structure using SAXS
SAXS measurements were performed at the 4C beamline
of the PAL. A light source from an in-vacuum undulator
20 (IVU 20: 1.4 m length, 20 mm period) of the Pohang
Light Source II (PLS storage II) ring was focused on the
sample, utilizing a vertical focusing toroidal mirror coated
with rhodium and monochromatized with an Si (III)
double crystal monochromator (DCM), giving an X-ray
beam of wavelength 1.110 Å. The detector was a Rayo-
nix 2D SX165, a two dimensional (2D) charge-coupled
detector (Evanston, IL, USA). The sample-to-detector
distance for SAXS was 2.0 m. The scattering angle was
calibrated with poly(styrene-b-polyethylene-b-polybu-
tadiene-b-polystyrene) block copolymer standards. The
solution sample cell with mica windows was 10 μm
thick with a volume of 50 μL, and it had an X-ray beam
path length of 0.7 mm. All scattering measurements
were conducted in the sample buffer containing 25 mM
HEPES (pH 7.0) and 150 mM NaCl at 25°C. Because the
scattering pattern was closely correlated with radiation
damage, the SAXS data were collected in two successive
timeframes of 30 s each, to monitor radiation damage.
The absence of changes in the scattering patterns over
time was confirmed, indicating that no radiation damage
occurred during the scattering measurements. SAXS mea-
surements were performed on protein solutions over the
concentration range 1–15 mg/mL to obtain good-quality
scattering data without any interference between the pro-
tein molecules (i.e., to eliminate any concentration effect).
Scattering data were collected for 30 s. Each 2D scattering
pattern obtained was circularly averaged from the beam
center, normalized to the transmitted X-ray beam inten-
sity, and corrected for scattering arising from the buffer
solvent [21].
SAXS data analysis
The experimental scattering patterns of SAXS were an-
alyzed with a scattering program GNOM [22] to calcu-
late the pair distance distribution function p(r) curve,
expressed as follows:




qrI qð Þ sin qrð Þdq
where q is the magnitude of the scattering vector defined
by q = (4π/λ)sinθ, 2θ is the scattering angle, λ is the wave-
length of the X-ray beam, and r is the distance between
the paired scattering elements in the protein. The radius
of gyration from a Guinier plot (Rg,G) can be calculated
by fitting the measured scattering data with the Guinier
equation [23], expressed as follows:
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method based on the p(r) curve. From the p(r) function,
not only I(0) from the full scattering curve but also the
maximum diameter of a given protein (Dmax) can be
obtained from the distance at which p(r) approaches zero.
Rg,p(r) is expressed by the following equation:
R2g;p rð Þ ¼
Z
r2p rð Þ dr
2
Z
p rð Þ dr
Structural modeling and comparison among wild-type,
mutant PmrD, and the crystal structure
The ab initio model-determination program GASBOR
[24] was used to reconstruct the models of wild-type
and mutant E. coli PmrD in solution. The reconstructed
models were obtained without imposing any symmetry
restrictions, and were averaged using DAMAVER [25].
The atomic coordinates of the crystallographic model of
PmrD from the crystal structure [PDB: 4HN7] were con-
verted into the SAXS curve using the CRYSOL program
[26]. The SUPCOMB program was used to superpose
the crystal structure onto the SAXS models recon-
structed from the experimental data [27].
Results and discussion
Overall crystal structure of E. coli PmrD
Prior to elucidation of the protein structure of E. coli
PmrD, its amino acid sequences were compared with
those of other species. As shown in Figure 1A, the amino
acid sequences are highly conserved and their overall
structures are coterminous. However, there are slight
differences in the N-terminal (alignment number, ap-
proximately 10–18) and C-terminal (alignment number,
approximately 83–88) regions. Structural determination
was carried out to clarify the discrepancies in PmrD
among various species.
The crystal structure of E. coli PmrD was initially solved
using the molecular-replacement method with the starting
model, the NMR structure of E. coli PmrD [PDB: 2JSO].
According to the electron-density map, 88 residues were
generally high quality, whereas the C-terminal region of
the data was unclear. With the refinement program
(REFMAC, CCP4i suite), the final structure of PmrD was
refined at 2.00 Å so that the Rwork and Rfree values be-
tween the coordinates and the structure factors were
21.1% and 25.4%, respectively. The crystal structure of E.
coli PmrD [PDB: 4HN7] was composed of a C-terminal α-
helix and an anti-parallel β-barrel containing six β-strands
(Figure 1B). The secondary structures of PmrD were de-
fined via the MOLMOL [28] program (β1: Trp3-Lys7; β2:
Arg16-Asp23; β3: Lys29-Lys35; β4: Leu45-Pro48; β5:Leu53-Ile56; β6: Glu59-Ser71; α-helix: Pro74-Ala84). Four
long β-strands (β1, β2, β3, and β6) are located near the
α-helix, and two short β-strands (β4 and β5) are situated
on the opposite side of the α-helix. In addition, the surface
electrostatic potential representations of E. coli PmrD
were constructed using the PyMOL visualization program
(Figure 2). The findings show many charged regions,
including electropositive surfaces (surface1: Lys6, Lys7,
Lys29, and Lys41; surface2: Arg16, Lys35, and Lys65;
surface3: Met1, Arg58 and Lys60; and surface4: Arg79
and Lys82). Among these electropositive regions, surface1
was charged broadly, and surface2 and surface3 were lo-
cated near each other. It can be expected that the surface1
or surface2-surface3 regions might interact with the elec-
tronegative region of PmrA (the phosphorylation site,
Asp51) to inhibit the dephosphorylation of PmrA.
Comparison of the E. coli PmrD crystal structure with
other structures
The X-ray crystal structure of E. coli PmrD has numer-
ous similarities to the NMR structure of the proteins,
including six β-strands, an anti-parallel β-barrel with
the topology of 6-3-2-1-4-5-6, and Greek-key topology.
These characteristics also exist in KP-PmrD [29]. How-
ever, the PmrD proteins display some distinctions, such
as the length of each strand, the definitude of structures,
and the electrostatic potentials. In particular, the crystal
structure exhibits well-defined secondary structures and
one disulfide bond, in contrast to the E. coli NMR struc-
ture. The structure shows a disulfide bond between the
Cys9 residue in the β1 strand and the Cys81 residue in the
α-helix (Figure 3). The difference between our structure
and that of the NMR is highlighted by factors such as the
presence of several reducing agents, and the presence of
the disulfide bond is confirmed by further biochemical ex-
periments. This disulfide bond might contribute to the
stabilization and fixation of the α-helix within the overall
structure.
In accordance with the results of PDBe Fold (version
2.51) [30], ten PDB structures were found with Z-scores
over 4.0 for the crystal structure of PmrD. Some models
with Z-scores over 4.7 that shared a β-barrel structure
containing several β-strands were superimposed onto
the PmrD structure, as shown in Figure 4. The fold of E.
coli PmrD belongs to the OB-fold domain, a conserved
domain in bacteria and archaea. The OB-fold proteins
with a five-stranded beta barrel structure can bind to
nucleotides, proteins, and ions, and also have a special
fold-related binding face (the center of β2 and β3),
depending on the length and sequence of loops 2 and 4
[31]. The crystal structure of excretory-secretory protein
2 has two intra-disulfide bonds, one of which contributes
to the stability of the C-terminal region in the same way
as in E. coli PmrD [32].
Figure 1 Sequence alignment and crystal structure of E. coli PmrD. (A) Sequence alignment between the PmrD proteins of E. coli and other
bacteria. The results of the sequence alignment are represented as conservation, quality, and consensus using the Clustal Omega program. All
sequences were obtained from NCBI. (E. coli PmrD, NP_416762.2; S. enterica PmrD, NP_456847.1; Shigella flexneri PmrD, NP_708145.1; KP-PmrD,
YP_002237594.1). (B) Crystal structure of E. coli PmrD. The overall structure of E. coli PmrD is exhibited as a ribbon model. The secondary
structures are indicated by the one α-helix (α1), six β-strands (β1, β2, β3, β4, β5, and β6), and loops in the ribbon model.
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lacking in the intra-disulfide bond
To reveal the role of the disulfide bond in PmrD, C9A-
mutated PmrD was generated by point mutation, resulting
in the removal of the disulfide bridge. Prior to determiningFigure 2 The electrostatic potential of E. coli PmrD. Surface illustration
electropositive regions in the PmrD monomer (surface1, surface2, surface3,the structural disparity, the alteration of the PmrD function
in the TCS, especially binding with PmrA, was validated
through native gel electrophoresis and the SPR measure-
ment. Because the lack of interaction between PmrD and
PmrA inhibits the second pathway for the activation of theof E. coli PmrD colored by the electrostatic potential. There are four
and surface4).
Figure 3 Disulfide bond of E. coli PmrD between Cys9 residue
in the β1 strand and Cys81 residue in the α-helix.
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PmrD is highly significant to the investigation of LPS modi-
fication in E. coli. For the gel analysis, highly purified PmrD
and C9A PmrD were incubated with recombinant E. coli
PmrA. As represented in Figure 5A, although the ratio of
PmrA to wild-type PmrD was changed from 1 to 3, there
was no multimer band in the gel. The higher ratio of wild-
type PmrD did not affect the binding of wild-type PmrD
with PmrA, in accordance with the previous report that E.
coli PmrD did not interact with PmrA [14]. Elimination of
the intra-disulfide bond in PmrD showed no distinct differ-
ences in the interaction of PmrD and PmrA, suggestingFigure 4 Rotation view of the superimposed models using the PDBe
90° on the horizontal axis and represented with the Jmol viewer (Yellowish
structure of E. coli PmrD: 2JSO; Sky-blue, the NMR structure of KP-PmrD: 2R
the crystal structure of excretory-secretory protein 2: 3NSW).that the internal disulfide bond does not play a major role
in binding with PmrA to prevent the dephosphorylation of
PmrA (Figure 5B).
The functional change in C9A PmrD was further dem-
onstrated in detail, based on the SPR technique. After the
His-tagged wild-type PmrD or mutant PmrD was immobi-
lized onto the NTA chip by a coordinate covalent bond,
triplicate injections of PmrA were performed at concen-
trations of 0.1, 1, 3, and 5 μM. The response signals at
equilibrium following the injections were utilized to plot
the response versus the PmrA concentrations to obtain
the dissociation constant (Kd). In the case of wild-type
PmrD, PmrA exhibited a low binding affinity to wild-type
PmrD as expected, with resulting difficulty in calculating
the Kd value (Figure 6A and 6B). Based on the steady-state
method: If Kd is larger than half of the highest concentra-
tion in the response-versus-concentrations graph, it can-
not be calculated from the data. The same outcome was
also observed in the C9A PmrD result, as represented in
Figure 6C and 6D. There was no significant interaction
between PmrA and mutant PmrD, indicating that the in-
ternal disulfide bond does not contribute to the function
of PmrD.
Confirmation of the structural variation of C9A PmrD
In the crystal structure of E. coli PmrD, it has been
shown that the intra-disulfide bond may influence the
maintenance of the overall structure. To judge the
structural discrepancy between wild-type and mutant
PmrD, specific experiments were conducted, including
size-exclusion chromatography and DLS. Wild-type andFold program. The superimposed models were rotated at an angle of
-green, the crystal structure of E. coli PmrD: 4HN7; Blue, the NMR
QX; Yellow, the crystal structure of T. kodakaraensis HypC: 2Z1C; Wine,
Figure 5 Native gel electrophoresis for verifying the binding of
wild-type and mutant PmrD with PmrA. Sample solutions with
various ratios of PmrD to PmrA were prepared in 20 μL of reaction
buffer (20 mM Tris–HCl, pH 7.8, 5 mM MgCl2, and 100 mM KCl) and
incubated at 4°C for 1 h. The samples were loaded onto a 4% native
polyacrylamide gel that was pre-run at 12 V/cm for 20 min, and they
were analyzed at room temperature at 12 V/cm for 80 min in 1X TBE
buffer. The gels were stained with Coomassie Blue. (A) Wild-type
PmrD. (B) Mutant PmrD.
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(GE Healthcare Life Science, Sweden). An analogous facet
was observed in the profiles that displayed aggregation
(~42 mL), dimer (~70 mL), and monomer (~80 mL)
peaks. In particular, the elution volumes of the wild-type
and mutant monomers were 82.014 mL and 82.000 mL,
respectively, implying that their sizes obtained by size-
exclusion chromatography were indistinguishable.
The DLS method is known to offer relatively accurate
information on the size distribution profile in solution,
and was therefore used to more precisely ascertain the
size difference between wild-type and mutant PmrD.
Through the triplicate measurements, the average sizes of
wild-type and mutant PmrD were calculated as 3.668 ±
0.069 nm and 3.870 ± 0.057 nm, respectively. As exhibited
in Additional file 2: Figure S1, the size of mutant PmrD at
the maximum peak is larger than that of the wild-type
form, and the overall distribution of C9A PmrD tends to-
ward large particle sizes, indicating that the exclusion of
the intra-disulfide bond in PmrD induces an increase in
the overall size. This suggests that the disulfide bondmight play an important role in the stabilization and fix-
ation of the α-helix within PmrD.
Reconstruction and evaluation of the solution structures
of PmrD based on SAXS
SAXS is a valuable technique for analyzing the entire
shape and size of target molecules in solution, and can
provide more accurate size estimation than that achieved
by size-exclusion chromatography or DLS. We introduced
this method to clarify the structural transition of mutant
PmrD lacking the intra-disulfide bond. The scattering
patterns for E. coli PmrD were obtained from the 4C
beamline at PAL. The measurements were taken at room
temperature at 2.0 m from the CCD detector. Additional
file 3: Figure S2 represents the SAXS profiles of wild-type
and mutant PmrD measured in the sample buffer con-
taining 25 mM HEPES (pH 7.0) and 150 mM NaCl.
Additionally, the scattering data were contrasted with
the theoretical SAXS profile evaluated from the PmrD
crystal structure. All scattering patterns were similar,
and the residuals of each scattering pattern displayed no
systematic errors (Additional file 4: Figure S3). The
Guinier plots and residuals were constructed from the
scattering curve (Additional file 5: Figure S4). The radius
of gyration (Rg,G) values and the scattering patterns
show no dependence on the concentration of the pro-
tein, implying that there is no interparticle interaction
between the proteins. The plots exhibit linear character-
istics in the Guinier q regions (q = 1.3Rg, globular pro-
tein) and offer structural information to estimate Rg,G.
The calculated Rg,G values of wild-type and mutant
PmrD were 14.10 Å and 14.63 Å, respectively. Addition-
ally, C values were calculated by the below equation to
demonstrate the availability of data in the range from
0.2-0.3 Å−1.






The S/N ratios were 3.0534 and 2.4870, and the calcu-
lated C values were 0.2950 and 0.246137 for wild-type and
mutant PmrD, respectively. Therefore, the data range
from 0.2 to 0.3 Å−1 is acceptable.
Although the Guinier method is expedient to derive
the radius of the target particles, it is influenced by several
factors. Compared with the computationally straightfor-
ward Guinier function, the pair distance distribution func-
tion (p(r)) is comparatively unaffected by various factors
such as the residual intermolecular interactions and the
formation of aggregation, because it employs the entire
scattering curve. Therefore, the maximum particle di-
mension (Dmax) and the radius of gyration (Rg,p(r)) were
derived from the p(r) function displayed in Additional
file 6: Figure S5A (Dmax: 43.1 Å, Rg,p(r): 14.04 ± 0.02 for
Figure 6 SPR for the measurement of the binding strength between PmrD and PmrA. The His-tagged wild-type and mutant PmrD were
separately immobilized onto the NTA sensor chip in the running buffer (10 mM HEPES, 150 mM NaCl, 50 μM EDTA, 0.005% Tween 20, and
pH 7.4). PmrA proteins with various concentrations (0.1, 1, 3, and 5 μM) were applied to a PmrD-modified channel under a continuous flow of
20 μL/min at 25°C using the Biacore T100 biosensor system. (A) Binding kinetics for wild-type PmrD with PmrA. (B) Plot based on the steady-
state method for binding between wild-type PmrD and PmrA. (C) Binding kinetics for mutant PmrD with PmrA. (D) Plot based on the steady-
state method for binding between mutant PmrD and PmrA.
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mutant PmrD). Each qmin and qmax value was also pre-
sented (qmin: 0.035, qmax: 0.3317 for wild-type PmrD;
qmin: 0.035, qmax: 0.3317 for mutant PmrD). All values
from the Guinier plots and pair distance distribution
functions are listed in Additional file 7: Table S2. The
constructed p(r) functions present single peak patterns,
which is characteristic of compact globular particles.
The globular shapes of wild-type PmrD and C9A PmrD
were also substantiated via the Kratky plots as shown in
Additional file 6: Figure S5B. The similarity between Rg,G
and Rg,p(r) indicates that the real space structure is pre-
cisely estimated from the scattering profile. In addition,
the differences in Dmax and Rg,p(r) between wild-type
PmrD and C9A PmrD apparently suggest that the intra-
disulfide bond in E. coli PmrD functions as a supporting
force for the overall structure.
Because the p(r) function is an expression of the scatter-
ing profile in real space, it can be used to visualize target
molecules. The ab initio SAXS model-independent struc-
tural models of wild-type and mutant E. coli PmrD were
reconstructed using the GASBOR [24] and DAMAVER
[25] programs, utilizing the GNOM results as a starting
file. Based on specific information within the GNOM file,
the GASBOR program established a model via a simulated
annealing strategy. The 3D representations of proteinswere acquired without assigning any restrictions on the
symmetry or anisometry of the molecules. Each SAXS
model was predicted 12 times and averaged via DAMA-
VER. Figure 7 shows the reconstructed solution structures
of wild-type and mutant PmrD. Both have similar spher-
ical structures, making it difficult to ascertain structural
inequalities with only the figures.
To validate the usefulness of the SAXS models, the
SUPCOMB superimposition program was used with
template files such as the ab initio SAXS models and
the crystal structure of E. coli PmrD. As shown in
Figure 8, the superimposition models suggest that the
PmrD crystal structure fits well to the ab initio SAXS
models of the wild-type and dimer forms. The struc-
tural consentaneity between the crystal and modeled
structures was substantiated quantitatively by means
of normalized spatial discrepancy (NSD). The NSD
algorithm facilitates rapid superimposition of structural
models and offers useful information about the similarity
between the models. It is expressed as the standard devia-
tions for one-dimensional data sets. All NSD values be-
tween the crystal structure and the ab initio models were
less than 0.6, implying that the reconstructed SAXS
models were nearly identical to the crystal structure, and
that the mutant PmrD structure was also akin to wild-
type PmrD.
Figure 7 Ab initio models reconstructed from SAXS data using GASBOR. The SAXS models are shown as sphere models. (A) Wild-type PmrD.
(B) Mutant PmrD.
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In summary, the X-ray crystal structure of E. coli PmrD
was determined at 2.00 Å resolution, showing that the
structure comprised the C-terminal α-helix and the anti-
parallel β-barrel containing six β-strands. Moreover,
there is a distinguishing disulfide bond between the
Cys9 residue in the β1 strand and the Cys81 residue in
the α-helix, unlike for the other structures of PmrD in
the crystal structure. Additional experiments offered
more detailed characterization of the intra-disulfide
bond. Native gel electrophoresis and SPR measurements
showed that the removal of the disulfide bridge in PmrD
did not influence the innate role of E. coli PmrD. On the
other hand, the disruption of the internal bond resulted
in increased overall size of PmrD, as demonstrated by
size-exclusion chromatography and DLS. This structural
alteration was further confirmed via ab initio SAXS
modeling. Well-reconstructed SAXS models gave an
abundance of information, including overall shapes and
sizes.Figure 8 Superimposition between the X-ray crystal structure and S
superimposition was performed in SUPCOMB. The X-ray crystal structure
(B) Mutant PmrD.The Groisman group has recently published new find-
ings on discrepancies in the polymyxin B-resistance
pathway among several bacteria [33]. They replaced the
E. coli pmrB gene with the Salmonella homolog, result-
ing in the resistance of E. coli to polymyxin B under
PmrD-inducing conditions. This result implies that dis-
parities in the polymyxin B-resistance pathway among
bacteria could stem from other factors, such as pmrB,
rather than from structural differences between the
PmrD proteins. Nevertheless, obvious reasons for the
discrepancy have not been investigated; therefore, the
structural analysis of PmrD is still significant. Our group
has been continuously attempting to resolve the structures
of PmrA and PmrB. It is anticipated that this investigation
will provide critical insights into the bacterial signal-
transduction mechanism.
Availability of supporting data
The data sets supporting the results of this article are
included within the article and its additional files.AXS models of wild-type and mutant E. coli PmrD. The
is displayed as a ribbon diagram. (A) Wild-type PmrD.
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Additional file 1: Table S1. Data and refinement statistics.
Additional file 2: Figure S1. Size distributions of wild-type and mutant
E. coli PmrD measured by DLS.
Additional file 3: Figure S2. SAXS data. Experimental scattering curves
of wild-type and mutant E. coli PmrD. The theoretical SAXS profile evalu-
ated from the PmrD crystal structure [PDB: 4HN7] was also plotted.
Additional file 4: Figure S3. Residuals of the scattering patterns of
the crystal structure and SAXS data for: (A) wild-type PmrD. (B) mutant
PmrD.
Additional file 5: Figure S4. (A) Guinier plots for wild-type PmrD and
mutant PmrD. The right table shows the slopes and Rg,G values for each
plot. (B) Residuals of wild-type and mutant PmrD.
Additional file 6: Figure S5. (A) Pair distance distribution function p(r)
profile of wild-type and mutant E. coli PmrD using GNOM program. (B)
Kratky plots for wild-type and mutant E. coli PmrD.
Additional file 7: Table S2. Parameters calculated from the Guinier
plots and pair distance distribution functions.
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